A large region within the Rous sarcoma virus matrix protein is dispensable for budding and infectivity

Journal of Virology

Volumn 70, Issue 4, 1996, Pages 2269-2276

  Nelle, Timothy D ^a   Wills, John W ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MATRIX PROTEIN; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RNA VIRUS INFECTION; ROUS SARCOMA ONCOVIRUS; VIRUS INFECTIVITY; VIRUS PATHOGENESIS; VIRUS REPLICATION;

EID: 0029997457     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.4.2269-2276.1996     Document Type: Article

References (58)

1. Argos, P. 1990. An investigation of oligopeptides linking domains in protein tertiary structures and possible candidates for general gene fusion. J. Mol. Biol. 211:943-958.
2. Bennett, R. P., T. D. Nelle, and J. W. Wills. 1993. Functional chimeras of the Rous sarcoma virus and human immunodeficiency virus Gag proteins. J. Virol. 67:6487-6498.
3. Bennett, R. P., S. Rhee, R. C. Craven, E. Hunter, and J. W. Wills. 1991. Amino acids encoded downstream of gag are not required by Rous sarcoma virus protease during Gag-mediated assembly. J. Virol 65:272-280.
4. Bryant, M., and L. Ratuer. 1990. Myristoylation-dependent replication and assembly of human immunodeficiency virus 1. Proc. Natl. Acad. Sci. USA 87:523-527
5. Bukrinsky, M. I., S. Haggerty, M. P. Dempsey, N. Sharova, A. Adzhufoel, L. Spitz, P. Lewis, D. Goldfarb, M. Emerman, and M. Stevenson. 1993. A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells Nature (London) 365:666-669
6. 2 terminus of Src. Biochemistry 33:13093-13101.
7. Craven, R. C., R. P. Bennett, and J. W. Wills. 1991. Role of the avian retroviral protease in the activation of reverse transcriptase during virion assembly. J. Virol. 65:6205-6217.
8. Craven, R. C., A. E. Leure-duPree, C. R. Erdie, C. B. Wilson, and J. W. Wills. 1993. Necessity of the spacer peptide between CA and NC in the Rous sarcoma virus Gag protein. J. Virol. 67:6246-6252.
9. Craven, R. C., A. E. Leure-duPree, R. A. Weldon, and J. W. Wills. 1995. Genetic analysis of the major homology region of the Rous sarcoma virus Gag protein. J. Virol 69:4213-4227.
10. src myristylation and membrane association and for cell transformation. Mol. Cell. Biol. 4:1834-1842.
11. Dong, J., J. W. Dubay, L. G. Perez, and E. Hunter. 1992 Mutations within the proteolytic cleavage site of the Rous sarcoma virus glycoprotein define a requirement for dibasic residues for intracellular cleavage. J. Virol. 66:865-874.
12. Erdie, C. R., and J. W. Wills. 1990. Myristylation of Rous sarcoma virus Gag protein does not prevent replication in avian cells J Virol. 64:5204-5208
13. Fields, B. N., and D. M. Knipe. 1990 Virology. Raven Press, New York.
14. Gebhardt, A., J. V. Bosch, A. Ziemiecki, and R. R. Friis. 1984. Rous sarcoma virus ply and gp35 can be chemically crosslinked to high molecular weight complexes. An insight into virus assembly. J. Mol. Biol. 174:297-317.
15. Gottlinger, H. G., T. Dorfman, J. G. Sodroski, and W. A. Haseltine. 1991. Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. Proc Natl. Acad. Sci USA 88:3195-3199.
16. Gottlinger, H. G., J. G. Sodroski, and W. A. Haseltine. 1989. Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 86:5781-5785.
17. Hunter, E. 1994. Biological techniques for avian sarcoma viruses. Methods Enzymol. 58:379-392.
18. Hunter, E., J. C. Bennett, A. Bhown, R. B. Pepinsky, and V. M. Vogt. 1983. Amino-terminal ammo acid sequence of p10, the fifth major Gag polypeptide of avian sarcoma and leukemia viruses. J. Virol 45:885-888.
19. Jørgensen, E. C., F. S. Pedersen, and P. Jørgensen. 1992. Matrix protein of Akv murine leukemia virus: genetic mapping of regions essential for particle formation. J. Virol. 66:4479-4487.
20. Katoh, I., H. Kyushiki, Y. Sakamoto, Y. Ikawa, and Y. Yoshinaka. 1991. Bovine leukemia virus matrix-associated protein MA(p15): further processing and formation of a specific complex with the dimer of the 5′-terminal genomic RNA fragment. J. Virol. 65:6845-6855.
21. Krishna, N. K., J. B. Bowzard, R. P. Bennett, and J. W. Wills. 1995. Unpublished data.
22. Leis, J., D. Baltimore, J. M. Bishop, J. Coffin, E. Fleissner, S. P. Goff, S. Oroszlan, H. Robinson, A. M. Skalka, H. M. Temin, and V. Vogt. 1988. Standardized and simplified nomenclature for proteins common to all retroviruses. J. Virol. 62:1808-1809.
23. Massiah, M. A., M. R. Starich, C. Paschall, M. F. Summers, A. M. Christensen. and W. I. Sundquist. 1994. Three-dimensional structure of the human immunodeficiency virus type 1 matrix protein. J. Mol. Biol. 244:198-223.
24. Matthews, S., P. Barlow, J. Boyd, R. Russell, H. Mills, M. Cunningham, N. Meyers, N. C. Burns, A. Kingsman, and I. Campbell. 1994. Structural similarity between the p17 matrix protein of HIV-1 and interferon-gamma. Nature (London) 370:666-668.
25. McLaughlin, S., and A. Aderam. 1995. The myristoyl-eleecrostatic switch: a modulator of reversible protein-membrane interactions Trends Biochem. Sci. 20:272-276.
26. Parent, L. J., R. P. Bennett, R. C. Craven, T. D. Nelle, N. K. Krishna, J. B. Bowzard, C. B. Wilson, B. A. Puffer, R. C. Montelaro, and J. W. Wills. 1995. Positionally independent and exchangeable late budding functions of the Rous sarcoma virus and human immunodeficiency virus Gag proteins. J. Virol. 69:5455-5460.
27. Parent, L. J., C. B. Wilson, M. D. Resh, and J. W. Wills. 1996. Evidence for a second function of the MA sequence in the Rous sarcoma virus Gag protein. J. Virol. 70:1016-1026.
28. Peitzsch, R. M., and S. McLaughlin. 1993. Binding of acylated peptides and fatty acids to phospholipid vesicles, pertinence to myristoylated proteins. Biochemistry 32:10436-10443.
29. src can direct myristylation and plasma membrane localization when fused to heterologous proteins. Nature (London) 346:84-86.
30. src. Proc. Natl. Acad. Sci. USA 82:1623-1627.
31. Pepinsky, R. B. 1983. Localization of lipid-protein and protein-protein interactions within the murine retrovirus gag precursor by a novel peptide-mapping technique. J. Biol. Chem 258:11229-11235.
32. Pepinsky, R. B., D. Cappiello, C. Wilkowski, and V. M. Vogt. 1980. Chemical crosslinking of proteins in avian sarcoma and leukemia viruses. Virology 102:205-210.
33. Pepinsky, R. B., R. J. Mattaliano, and V. M. Vogt. 1986. Structure and processing of the p2 region of avian sarcoma and leukemia virus gag precursor polyprotein. J. Virol. 58:50-58
34. Pepinsky, R. B., and V. M. Vogt. 1979. Identification of retrovirus matrix proteins by lipid-protein cross-linking. J. Mol. Biol. 131:819-837.
35. Pepinsky, R. B., and V. M. Vogt. 1983. Purification and properties of a fifth major viral Gag protein from avian sarcoma and leukemia viruses. J. Virol. 45:648-658.
36. Pepinsky, R. B., and V. M. Vogt. 1984. Fine-structure analyses of lipid-protein and protein-protein interactions of Gag protein p19 of the avian sarcoma and leukemia viruses by cyanogen bromide mapping J Virol. 52:145-153.
37. gag is essential for virus particle formation by Moloney murine leukemia virus. Proc. Natl. Acad. Sci. USA 83:7246-7250.
38. Resh, M. D. 1994. Myristylation and palmitylation of Src family members: the fats of the matter. Cell 76:411-413.
39. Rhee, S. S., and E. Hunter. 1987. Myristylation is required for intracellular transport but not for assembly of D-type retrovirus capsids. J. Virol 61:1045-1053.
40. Rhee, S. S., and E. Hunter. 1990. Structural role of the matrix protein of type D retroviruses in Gag polyprotein stability and capsid assembly J. Virol. 64:4383-4389.
41. Sakalian, M., J. W. Wills, and V. M. Vogt. 1994. Efficiency and selectivity of RNA packaging by Rous sarcoma virus Gag deletion mutants. J Virol. 68:5969-5981.
42. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory. Cold Spring Harbor, N.Y.
43. Sefton, B. M., and J. E. Buss. 1987. The covalent modification of eukaryotic proteins with lipid. J. Cell Biol 104:1449-1453.
44. gag) of avian sarcoma and leukemia viruses. J. Virol. 64:847-355.
45. Towler, D. A., J. I. Gordon, S. P. Adams, and L. Glaser. 1988. The biology and enzymology of eukaryotic protein acylation. Annu. Rev. Biochem. 57:69-99
46. Verderame, M. F., T. D. Nelle, and J. W. Wills. 1996. The membrane-binding domain of the Rous sarcoma virus Gag protein. J. Virol. 70:2664-2668.
47. Vogt, V. M., R. B. Pepinsky, and L. E. Southard. 1985. Primary structure of p19 species of avian sarcoma and leukemia viruses. J. Virol. 56:31-39.
48. Ward, P. L., and B. Roizman. 1994. Herpes simplex genes: the blueprint of a successful human pathogen. Trends Genet. 10:267-274.
49. Weldon, R. A., Jr., C. R. Erdie, M. G. Oliver, and J. W. Wills. 1990 Incorporation of chimeric Gag protein into retroviral particles J. Virol. 64:4169-4179.
50. Weldon, R. A., Jr., and J. W. Wills. 1993. Characterization of a small (25-kilodalton) derivative of the Rous sarcoma virus Gag protein competent for particle release. J. Virol. 67:5550-5561
51. Wills, J. W. 1989. Retro-secretion of recombinant proteins. Nature (London) 340:323-324.
52. Wills, J. W., C. E. Cameron, C. B. Wilson, Y. Xiang, R. P. Bennett, and J. Leis. 1994. An assembly domain of the Rous sarcoma virus Gag protein required late in budding. J. Virol. 68:6605-6618
53. Wills, J. W., and R. C. Craven. 1991 Form, function, and use of retroviral Gag proteins. AIDS 5:639-654. (Editorial review.)
54. Wills, J. W., R. C. Craven, and J. A. Achacoso. 1989. Creation and expression of myristylated forms of Rous sarcoma virus Gag protein in mammalian cells. J. Virol. 63:4331-4343
55. Wills, J. W., R. C. Craven, R. A. Weldon, Jr., T. D. Nelle, and C. R. Erdie. 1991. Suppression of retroviral MA deletions by the amino-terminal membrane-binding domain of p60src. J Virol. 65:3804-3812
56. Yu, X., Q.-C. Yu, T.-H. Lee, and M. Essex. 1992. The C terminus of human immunodeficiency virus typel matrix protein is involved in early steps of the viral life cycle. J. Virol. 66:5667-5670.
57. Yu, X., X. Yuan, Z. Matsuda, T.-H. Lee, and M. Essex. 1992. The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral enveloped protein into mature virions. J. Virol 66:4966-4971.
58. Zhou, W., L. J. Parent, J. W. Wills, and M. D. Resh. 1994. Identification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids. J. Virol. 68:2556-2569